The U.S. Food and Drug Administration (FDA) approved NEXIUM® delayed release capsules in children ages 12 to 17 for the short-term treatment of gastroesophageal reflux disease (GERD). NEXIUM was tested in adolescents ages 12 to 17 in a randomized, double-blind parallel group study in which a total of 149 patients, ages 12 to 17, with clinically diagnosed GERD were treated with either NEXIUM 20mg or NEXIUM 40 mg once a day for up to eight weeks. Reported side effects included headache,...
Read morePregnancy Tracker: 21 weeks, 3 days Size of the Baby: 10.5 ounces Biggest Obstacle: I'm tired because we're moving this weekend! ... Read more »
Last week Zogenix, Inc., a pharmaceutical company that develops products for treating central nervous system disorders and pain, announced... Read more »
On Monday, the pharmaceutical company Zogenix, Inc. announced the FDA had accepted for review their New Drug Application (NDA) for Zohydro... Read more »
In April, I reported on a new Migraine abortive medication, Trexima. Trexima combines sumatriptan (Imitrex) and naproxen sodium. Two... Read more »
The FDA has delayed approval for Actemra pending submission of extra product manufacturing and product label... Read more »
Source: ADAM Encyclopedia
Delayed ejaculation is a medical condition in which a male is unable to ejaculate, either during intercourse or with manual stimulation in the... Read more »
Source: ADAM Encyclopedia
Expectations after surgery Carpal tunnel release is successful in improving strength and decreasing pain in about 85% of patients, if these... Read more »
Source: eOrthopod
This is part two of a study started in 1986. The doctors decided to extend the study to look at results five to 12 years after lateral retinacular... Read more »
Brand Name: Dexedrine and Dextrostat Generic Name: dextroamphetamine sulfate Usage: Dexedrine is a sustained-release medication approved for... Read more »